1) oral malignant tumor
口腔恶性肿瘤
1.
ObjectiveTo retrospectively study the clinical data of several pedicle flaps used in reconstruction of soft tissue defects following oral malignant tumor resection and offer some references for pedicle flaps application.
方法对武汉大学口腔医学院1985—2006年期间346例口腔恶性肿瘤切除后软组织缺损患者,采用单一带蒂组织瓣行即刻修复的临床资料进行回顾性分析。
2) oral malignant tumors
口腔恶性肿瘤
1.
In this article we observed the expressions of PTN which expressed in oral malignant tumorsat genie and protein levels,using RT-PCR,Western-blotting,ICH and ISH,in order to explore the clinical value of it during the treatment of disease.
本文利用临床病理标本(癌、转移淋巴结、良性肿瘤、正常口腔组织),采用RT-PCR、WESTERN-BLOTTING、免疫组织化学(ICH)、原位杂交(ISH)检测方法来观察PTN 在口腔恶性肿瘤中的基因和蛋白水平的表达情况,从而探讨其在疾病治疗过程中的临床应用价值。
3) oral and maxillofacial malignancy
口腔颌面部恶性肿瘤
1.
Objective To determine the level of hyaluronic acid (HA) in serum of patients with oral and maxillofacial malignancy and to investigate the correlation between the levels of serum HA and stage of the malignant lesions and treatment response.
目的 检测口腔颌面部恶性肿瘤患者血清中透明质酸 (HA)的含量 ,探讨HA对口腔颌面部恶性肿瘤辅助诊断和治疗效果监测的价值。
2.
Objective: To explore levels of serum soluble CD44v6(sCD44v6) and hyaluronic acid (HA) in patients with oral and maxillofacial malignancy and to investigate the correlation between the levels of serum sCD44v6 and HA in patients and the type and stage of oral and maxillofacial malignancy.
但关于该肿瘤标志物在口腔颌面部恶性肿瘤方面的研究尚不多见，且目前研究仅局限于免疫组化方面，对其在口腔颌面部恶性肿瘤患者血清中含量的研究国内外尚未见报道。
4) malignant oral-maxillofacial tumors
口腔、颌面恶性肿瘤
1.
Objective:to discuss the clinical integrated treatment methods of malignant oral-maxillofacial tumors.
目的探讨分析口腔、颌面恶性肿瘤综合治疗的疗效。
5) malignant abdominal tumors
腹腔恶性肿瘤
1.
Clinical study of MMC-fibrin glue mixture as Adjuvant Chemotherapy in patients with malignant abdominal tumors;
以生物蛋白胶为载体配合丝裂霉素缓释化疗腹腔恶性肿瘤的临床研究
6) pelvic malignancies
盆腔恶性肿瘤
1.
The clinical study of stereotactic focus hyperthermia combined with rediotherapy for pelvic malignancies;
立体聚焦热疗加放射治疗盆腔恶性肿瘤的临床研究
补充资料：恶性肿瘤的TNM分期
恶性肿瘤的TNM分期
malignant tumor TNM classification
国际抗癌联盟提出的TNM分期，T是指原发性肿瘤(tumor)，N为淋巴结(node)，M为远处转移(metastasis)。再根据肿瘤体积和肿瘤浸润范围，在其字母后标以0～4的数字，1代表小，4代表大，0为无。有远处转移为M1，无为M0。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条